-
- Posted Thursday October 4, 2012
TGen's Dr. Daniel Von Hoff delivers first Lori Groetken Memorial Lecture
Award presented at Washington University in St. Louis to research leader in pancreatic cancer
October 4, 2012
Dr. Daniel Von Hoff, Physician-In-Chief of the Translational
Genomics Research Institute (TGen) is the first recipient of the
Lori Groetken Memorial Lecture and Award.
Dr. Von Hoff's lecture, "A Relentless Molecular Pursuit Approach
to Take Out Pancreatic Cancer," is at noon Oct. 5 at the Siteman
Cancer Center at Washington University in St. Louis.
"I am extremely honored and humbled to be the first recipient of
the Lori Groetken Memorial Lecture, and I look forward to the
opportunity to present this lecture and discuss how we can make
advances together against this terrible cancer," said Dr. Von
Hoff.
The lecture and award is in memory of Lori Groetken, a pancreatic
cancer patient who fought the disease for two years. She and her
husband, Cecil, were at the forefront of raising funds for
pancreatic cancer research at the Siteman Cancer Center. The annual
lecture series in her name has been created to recognize
individuals whose research makes substantial contributions to the
field of pancreatic cancer research.
"In light of your significant contributions in leading the world
efforts in genomic research and novel therapy development in
pancreatic cancer research, you have been selected to be the
inaugural recipient for the Lori (Groetken) Memorial Lectureship,"
according to a letter to Dr. Von Hoff from Dr. Andrea Wang-Gillam,
Assistant Professor in the Division of Oncology, Section of Medical
Oncology, at Washington University.
Dr. Von Hoff, M.D., F.A.C.P., is an internationally recognized
physician-scientist who has contributed to the development of
numerous anticancer agents, including paclitaxel, docetaxel,
irinotecan and gemcitabine. He also is the Chief Scientific Officer
of TGen's clinical trials at Scottsdale Healthcare's Virginia G.
Piper Cancer Center, Chief Scientific Officer at US Oncology,
Professor of Medicine at Mayo Clinic, and Clinical Professor of
Medicine at the University of Arizona College of Medicine.
A book published this year - The Creative Destruction of Medicine
by Dr. Eric Topol, Director of the Scripps Translational Science
Institute - describes Dr. Von Hoff as the nation's "leading
authority on pancreatic cancer."
In 2010, Dr. Von Hoff won a top award from the American Society of
Clinical Oncology (ASCO) for his cancer research. He received the
David A. Karnofsky Memorial Award and Lecture at ASCO's 46th Annual
Meeting "for his outstanding achievements in cancer research and
for his impact on the treatment of patients with cancer."
Dr. Von Hoff is the Co-Team Leader for the Stand Up To Cancer
(SU2C) Pancreatic Cancer "Dream Team," in which he leads a team
investigating how to cut off the fuel supply of nutrients to
pancreatic cancer cells.
Dr. Von Hoff founded the Pancreatic Cancer Research Team (PCRT),
an international network of clinical trials sites organized under
TGen Drug Development (TD2), a TGen subsidiary. PCRT
represents a consortium of 45 highly experienced investigators and
clinics from across the U.S. and Europe, dedicated to finding a
cure for pancreatic cancer, which annually kills more than 37,000
people in the U.S., and is the nation's 4th leading cause of cancer
death.
About TGen
The Translational Genomics Research Institute (TGen) is a
Phoenix-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. Research at
TGen is focused on helping patients with diseases such as cancer,
neurological disorders and diabetes. TGen is on the cutting edge of
translational research where investigators are able to unravel the
genetic components of common and complex diseases. Working with
collaborators in the scientific and medical communities, TGen
believes it can make a substantial contribution to the efficiency
and effectiveness of the translational process. For more
information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
